Skip to content

Study to evaluate the ability of a sublingual vaccine to induce the expression of trained immunity in peripheral blood cells

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516720-34-00
Acronym
MV130-SLG-039
Enrollment
48
Registered
2024-10-30
Start date
2023-03-31
Completion date
Unknown
Last updated
2024-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult males and non-pregnant females

Interventions

None listed

Sponsors

Inmunotek S.L.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026